One woman’s remarkable resolve to help give better treatment options for people with rare blood cancers - National
Publish Date: 2/3/2017
A better treatment option for people with the blood cancer myeloproliferative neoplasms (MPN), is one step closer to being made available to Australians, with the new drug interferon alfa-2a (Pegasys®), being discussed at today’s Pharmaceutical Benefits Advisory Committee (PBAC) meeting.
Breakthrough cancer drug venetoclax approved for use in Australia - National
Publish Date: 10/1/2017
New anti-cancer drug, venetoclax which has the power to ‘melt away’ advanced forms of chronic lymphocytic leukaemia (CLL) was recently granted approval by the Australian Therapeutic Goods Administration (TGA).